Undergrad Co-op – Finance/Accounting
Amgen
Summary
During this program, you will have the opportunity to partner with Amgen’s finance leaders and experience our mission-driven culture firsthand.
Job description
What You Will Do
During this program, you will have the opportunity to partner with Amgen’s finance leaders and experience our mission-driven culture firsthand.
Each summer intern will work 20 hours per week with an accounting/finance team for the duration of the program. Throughout the internship, they will be assigned multiple meaningful projects tied directly to our strategic and tactical goals. These projects give interns the opportunity to think analytically, build a strong foundation in corporate finance and accounting, learn systems and technology tools, work with multiple managers and gain valuable experience in the biotechnology industry.
In addition, each intern will benefit from the support and guidance of an assigned mentor, fellow interns, recruiting team members, and the greater Amgen community. Upon successful completion of the program, interns will be evaluated for a full-time position post-graduation.
- Develop a highly differentiated set of technical and financial skills as you tackle challenging projects
- Gain a deep understanding of your accounting/finance team and how it contributes to Amgen’s success
- Collaborate with fellow interns in a week-long multidisciplinary case study competition that will expose you to various aspects of our business including operations, sales and marketing, and forecasting (40hr/week required for this specific week in July)
- Attend weekly lunches during the summer months with Amgen executives and engage personally with leadership
- Network with colleagues across the company and enjoy full access to Amgen’s Employee Resource Groups
Program Eligibility Requirements
- Expected completion of one year of study from an accredited college or university prior to the internship commencing
- Expected continued enrollment in an accredited college or university following the internship program
- Student must be located in the United States for the duration of the internship program
- Must be available to work a part-time schedule
- Must be available to accept and commit to future full-time employment by July 2028, if offered
Basic Qualifications
- 18 years or older
- Currently enrolled in a full-time Bachelor’s Degree program from an accredited college or university with a 3.0 minimum GPA or equivalent
Preferred Qualifications
- Concentration in Economics, Business Administration, Biotechnology Management, Accounting or Finance
- Ability to demonstrate an understanding of basic financial analytical principles
- Effective communication and organizational skills
- Strong analytical skills with attention to detail
- Ability to manage competing priorities and meet deadlines in a fast-paced environment
- Experience with Microsoft Excel and PowerPoint
- Strong team mentality and ability to collaborate effectively with colleagues on complex assignments
Requirements
- 18 years or older
- Currently enrolled in a full-time Bachelor’s Degree program from an accredited college or university with a 3.0 minimum GPA or equivalent
- Expected completion of one year of study from an accredited college or university prior to the internship commencing
- Expected continued enrollment in an accredited college or university following the internship program
- Student must be located in the United States for the duration of the internship program
- Must be available to work a part-time schedule
- Must be available to accept and commit to future full-time employment by July 2028, if offered
Benefits
- Competitive benefits
- Collaborative culture
- Networking events
- Employee Resource Groups
- Mentorship
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.